143 related articles for article (PubMed ID: 38734788)
21. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
[TBL] [Abstract][Full Text] [Related]
22. The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.
Whitman SP; Caligiuri MA; Maharry K; Radmacher MD; Kohlschmidt J; Becker H; Mrózek K; Wu YZ; Schwind S; Metzeler KH; Mendler JH; Wen J; Baer MR; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Larson RA; Marcucci G; Bloomfield CD
Leukemia; 2012 Jul; 26(7):1713-7. PubMed ID: 22382894
[No Abstract] [Full Text] [Related]
23. IDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status.
Jeziskova I; Razga F; Bajerova M; Racil Z; Mayer J; Dvorakova D
Leuk Lymphoma; 2010 Dec; 51(12):2285-7. PubMed ID: 20929327
[No Abstract] [Full Text] [Related]
24. A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š; Cerovská E; Šálek C; Kundrát D; Ježíšková I; Folta A; Mayer J; Ráčil Z; Cetkovský P; Remešová H
Clin Epigenetics; 2022 Feb; 14(1):22. PubMed ID: 35148810
[TBL] [Abstract][Full Text] [Related]
25. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
He PF; Xu ZJ; Zhou JD; Li XX; Zhang W; Wu DH; Zhang ZH; Lian XY; Yao XY; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia.
de Leeuw DC; Verhagen HJ; Denkers F; Kavelaars FG; Valk PJ; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Leukemia; 2016 Mar; 30(3):742-6. PubMed ID: 26108690
[No Abstract] [Full Text] [Related]
27. Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q).
Rea B; Aggarwal N; Yatsenko SA; Bailey N; Liu YC
Mod Pathol; 2020 Apr; 33(4):566-575. PubMed ID: 31685963
[TBL] [Abstract][Full Text] [Related]
28. Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study.
Kamal AM; El-Hefny NH; Hegab HM; El-Mesallamy HO
Hematology; 2016 Dec; 21(10):567-575. PubMed ID: 27158980
[TBL] [Abstract][Full Text] [Related]
29. RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2‑deficient human acute myeloid leukemia.
Xu Y; Lin Y; Luo Y; Yang Y; Long B; Fang Z; Liu L; Zhang J; Zhang X
Oncol Rep; 2020 Oct; 44(4):1455-1466. PubMed ID: 32945515
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
[No Abstract] [Full Text] [Related]
31. Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway.
Padella A; Fontana MC; Marconi G; Fonzi E; Petracci E; Ferrari A; Baldazzi C; Papayannidis C; Ghelli Luserna Di Rorá A; Testoni N; Castellani G; Haferlach T; Martinelli G; Simonetti G
Blood Cancer J; 2021 Jan; 11(1):7. PubMed ID: 33414401
[No Abstract] [Full Text] [Related]
32. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.
Figueroa ME; Lugthart S; Li Y; Erpelinck-Verschueren C; Deng X; Christos PJ; Schifano E; Booth J; van Putten W; Skrabanek L; Campagne F; Mazumdar M; Greally JM; Valk PJ; Löwenberg B; Delwel R; Melnick A
Cancer Cell; 2010 Jan; 17(1):13-27. PubMed ID: 20060365
[TBL] [Abstract][Full Text] [Related]
33. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
[TBL] [Abstract][Full Text] [Related]
34. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
35. New opportunities and new problems for acute myeloid leukemia treatment.
Lahortiga I; Cools J
Haematologica; 2012 Jun; 97(6):796. PubMed ID: 22665527
[No Abstract] [Full Text] [Related]
36. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
37. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
[TBL] [Abstract][Full Text] [Related]
38. High BCL11A Expression in Adult Acute Myeloid Leukemia Patients Predicts a Worse Clinical Outcome.
Dong H; Shi P; Zhou Y; Yu Y; Guo X; Yao Y; Liu P; Xu B
Clin Lab; 2017 Jan; 63(1):85-90. PubMed ID: 28164500
[TBL] [Abstract][Full Text] [Related]
39. Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.
Fried I; Bodner C; Pichler MM; Lind K; Beham-Schmid C; Quehenberger F; Sperr WR; Linkesch W; Sill H; Wölfler A
Haematologica; 2012 Feb; 97(2):246-50. PubMed ID: 21993668
[TBL] [Abstract][Full Text] [Related]
40. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
